Phaeno Thera
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $15M
Investors
- 5
About Phaeno Thera
Based in Hangzhou, China and established in 2018, Phaeno Thera is a biomedical technology that focuses on the development of anti-infective drugs. The company has established an office and a biosafety secondary laboratory in Shanghai. The company engages in the development of anti-infective drugs. Its main products include anti-human cytomegalovirus (HCMV) new drug HN0141, and anti-herpes simplex virus (HSV) new drug HN0037.
Who invested in Phaeno Thera
5 investors across 2 rounds
See all investors in Phaeno Thera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Phaeno Thera
Who invested in Phaeno Thera?
Phaeno Thera has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Phaeno Thera raised?
Phaeno Thera has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Phaeno Thera last raise money?
Phaeno Thera's most recent round on record is a Series A, in Aug 2021.
What does Phaeno Thera do?
Based in Hangzhou, China and established in 2018, Phaeno Thera is a biomedical technology that focuses on the development of anti-infective drugs.
Where is Phaeno Thera headquartered?
Phaeno Thera is headquartered in Hangzhou, China.
Which VCs invest in companies like Phaeno Thera?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Phaeno Thera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Phaeno Thera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.